Back to article: Targeting LRH-1/NR5A2 to treat type 1 diabetes mellitus
FIGURE 1: Schematic overview of LRH-1 agonistic activation in favouring and anti-inflammatory and pro-islet regenerative environment implicating alpha-to-beta cell transdifferentiation. Pie charts depict the relative percentage of either immune or islet cells under the various conditions.